+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Biofilm formation by Stenotrophomonas maltophilia isolates from device-associated nosocomial infections



Biofilm formation by Stenotrophomonas maltophilia isolates from device-associated nosocomial infections



Revista Argentina de Microbiologia 39(4): 204-212



Medical devices are often colonized by bacteria which may cause severe infections. The aim of this work was to evaluate biofilm formation by S. maltophilia isolates from device-associated nosocomial infections. The 13 local isolates exhibited different capacities of biofilm formation on hydrophilic and hydrophobic surfaces. All isolates formed strong biofilms in polystyrene microplates, while strong, moderate or weak biofilms were detected in borosilicate (BS) or polypropylene (PP) tubes. The proficiency of biofilm formation was better evaluated by the level of crystal violet staining expressed relative to the final culture density. The microscopic analysis of biofilms formed on glass coverslips revealed the presence of a matrix of exopolysaccharides and microcolonies typical of biofilm architecture. Isolates with increased adhesion to BS showed larger microcolonies. According to our results, twitching correlated well with attachment to the three abiotic surfaces tested, while swimming only showed a slight correlation with biofilm formation on PP. Poor correlation was observed between cell surface hydrophobicity and biofilm formation. One of the highest biofilm-producing isolates adhered to urethral catheters of different materials, and exhibited an increased resistance to oxidative stress, one of the common stresses encountered by bacteria during the infection process due to the immune response.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 051805987

Download citation: RISBibTeXText

PMID: 18390153


Related references

Effect of environmental factors on biofilm formation by clinical Stenotrophomonas maltophilia isolates. Folia Microbiologica 52(1): 86-90, 2007

Temperature, pH and Trimethoprim-Sulfamethoxazole Are Potent Inhibitors of Biofilm Formation by Stenotrophomonas maltophilia Clinical Isolates. Polish Journal of Microbiology 66(4): 433-438, 2017

Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients. Bmc Microbiology 10: 102, 2010

Genome-wide identification of genes necessary for biofilm formation by nosocomial pathogen Stenotrophomonas maltophilia reveals that orphan response regulator FsnR is a critical modulator. Applied and Environmental Microbiology 81(4): 1200-1209, 2015

Activity of levofloxacin and ciprofloxacin on biofilms and planktonic cells of Stenotrophomonas maltophilia isolates from patients with device-associated infections. International Journal of Antimicrobial Agents 34(3): 260-264, 2009

Phenotypic and genotypic characterization of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis: genome diversity, biofilm formation, and virulence. Bmc Microbiology 11: 159, 2011

Multidrug resistance in clinical isolates of Stenotrophomonas maltophilia: roles of integrons, efflux pumps, phosphoglucomutase (SpgM), and melanin and biofilm formation. International Journal of Antimicrobial Agents 35(2): 126-130, 2010

Antimicrobial susceptibilities of a worldwide collection of Stenotrophomonas maltophilia isolates tested against tigecycline and agents commonly used for S. maltophilia infections. Antimicrobial Agents and ChemoTherapy 54(6): 2735-2737, 2010

Severe nosocomial infections due to Stenotrophomonas maltophilia. International Journal of Antimicrobial Agents 19(Suppl. 1): S99, 2002

Nosocomial Stenotrophomonas maltophilia infections in a university hospital. Mikrobiyoloji Bulteni 39(1): 25-33, 2005

Antimicrobial activities of gatifloxacin against nosocomial isolates of Stenotrophomonas maltophilia measured by MIC and time-kill studies. Antimicrobial Agents and ChemoTherapy 45(7): 2126-2128, 2001

Epidemiology of nosocomial infections due to Pseudomonas aeruginosa, Burkholderia cepacia and Stenotrophomonas maltophilia. Pathologie-Biologie 53(6): 341-348, 2005

Resistance analysis of Stenotrophomonas maltophilia isolated from nosocomial infections against 19 antimicrobial agents. Zhongguo Kangshengsu Zazhi 28(8): 477-481, 2003

Novel nosocomial infections by Stenotrophomonas maltophilia: first reported case from Lucknow, North India. Journal of Clinical Microbiology 41(8): 3989-3990, 2003

Emergence of Stenotrophomonas maltophilia nosocomial isolates in a Saudi children's hospital. Risk factors and clinical characteristics. Saudi Medical Journal 38(5): 521-527, 2017